Ellinor Grinde

1.1k total citations
15 papers, 883 citations indexed

About

Ellinor Grinde is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ellinor Grinde has authored 15 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ellinor Grinde's work include Receptor Mechanisms and Signaling (13 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Neuroscience and Neuropharmacology Research (4 papers). Ellinor Grinde is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Neuroscience and Neuropharmacology Research (4 papers). Ellinor Grinde collaborates with scholars based in United States. Ellinor Grinde's co-authors include Katharine Herrick‐Davis, Joseph E. Mazurkiewicz, Milt Teitler, Colleen M. Niswender, Ann E. Cowan, Barbara A. Weaver, Tara A. Lindsley, Christina Egan, Ann DuPre and Bryan Roth and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Annals of the New York Academy of Sciences.

In The Last Decade

Ellinor Grinde

15 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellinor Grinde United States 13 654 578 57 53 53 15 883
Laura Albizu France 9 512 0.8× 482 0.8× 94 1.6× 17 0.3× 22 0.4× 9 782
Ludo Kennis Belgium 7 537 0.8× 555 1.0× 31 0.5× 42 0.8× 7 0.1× 12 1.1k
B Roth United States 7 290 0.4× 307 0.5× 27 0.5× 46 0.9× 6 0.1× 11 547
Nikhil M. Urs United States 19 761 1.2× 586 1.0× 33 0.6× 53 1.0× 6 0.1× 36 1.1k
Thomas Steinkellner Austria 17 337 0.5× 497 0.9× 14 0.2× 33 0.6× 9 0.2× 29 736
Guillermo A. Yudowski United States 16 923 1.4× 616 1.1× 18 0.3× 15 0.3× 36 0.7× 28 1.4k
Marc Brugarolas Spain 9 425 0.6× 390 0.7× 30 0.5× 24 0.5× 8 0.2× 9 686
Hervé Ansanay France 15 520 0.8× 400 0.7× 48 0.8× 17 0.3× 6 0.1× 17 760
Alberto Bertollini Italy 15 413 0.6× 404 0.7× 9 0.2× 44 0.8× 22 0.4× 36 751
Sathasiva B. Kandasamy United States 14 198 0.3× 166 0.3× 74 1.3× 30 0.6× 16 0.3× 45 495

Countries citing papers authored by Ellinor Grinde

Since Specialization
Citations

This map shows the geographic impact of Ellinor Grinde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellinor Grinde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellinor Grinde more than expected).

Fields of papers citing papers by Ellinor Grinde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellinor Grinde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellinor Grinde. The network helps show where Ellinor Grinde may publish in the future.

Co-authorship network of co-authors of Ellinor Grinde

This figure shows the co-authorship network connecting the top 25 collaborators of Ellinor Grinde. A scholar is included among the top collaborators of Ellinor Grinde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellinor Grinde. Ellinor Grinde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Grinde, Ellinor, et al.. (2016). Beta2-adrenergic receptor homodimers: Role of transmembrane domain 1 and helix 8 in dimerization and cell surface expression. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1859(9). 1445–1455. 27 indexed citations
2.
Herrick‐Davis, Katharine, Ellinor Grinde, Tara A. Lindsley, et al.. (2015). Native Serotonin 5-HT2C Receptors Are Expressed as Homodimers on the Apical Surface of Choroid Plexus Epithelial Cells. Molecular Pharmacology. 87(4). 660–673. 38 indexed citations
3.
Herrick‐Davis, Katharine, Ellinor Grinde, Ann E. Cowan, & Joseph E. Mazurkiewicz. (2013). Fluorescence Correlation Spectroscopy Analysis of Serotonin, Adrenergic, Muscarinic, and Dopamine Receptor Dimerization: The Oligomer Number Puzzle. Molecular Pharmacology. 84(4). 630–642. 92 indexed citations
4.
Herrick‐Davis, Katharine, Ellinor Grinde, Tara A. Lindsley, Ann E. Cowan, & Joseph E. Mazurkiewicz. (2012). Oligomer Size of the Serotonin 5-Hydroxytryptamine 2C (5-HT2C) Receptor Revealed by Fluorescence Correlation Spectroscopy with Photon Counting Histogram Analysis. Journal of Biological Chemistry. 287(28). 23604–23614. 59 indexed citations
5.
Herrick‐Davis, Katharine, Ellinor Grinde, & Barbara A. Weaver. (2007). Serotonin 5-HT2C receptor homodimerization is not regulated by agonist or inverse agonist treatment. European Journal of Pharmacology. 568(1-3). 45–53. 14 indexed citations
6.
Herrick‐Davis, Katharine, Barbara A. Weaver, Ellinor Grinde, & Joseph E. Mazurkiewicz. (2006). Serotonin 5-HT2C Receptor Homodimer Biogenesis in the Endoplasmic Reticulum. Journal of Biological Chemistry. 281(37). 27109–27116. 92 indexed citations
7.
Grinde, Ellinor, et al.. (2005). Pharmacological properties of the Cys23Ser single nucleotide polymorphism in human 5-HT2C receptor isoforms. The Pharmacogenomics Journal. 5(4). 244–254. 31 indexed citations
8.
Herrick‐Davis, Katharine, et al.. (2005). Inhibition of Serotonin 5-Hydroxytryptamine2C Receptor Function through Heterodimerization. Journal of Biological Chemistry. 280(48). 40144–40151. 93 indexed citations
9.
Herrick‐Davis, Katharine, Ellinor Grinde, & Joseph E. Mazurkiewicz. (2004). Biochemical and Biophysical Characterization of Serotonin 5-HT2CReceptor Homodimers on the Plasma Membrane of Living Cells. Biochemistry. 43(44). 13963–13971. 69 indexed citations
10.
Barnes, William G., Ellinor Grinde, Dana R. Crawford, Katharine Herrick‐Davis, & Lindsay B. Hough. (2003). Characterization of a new mRNA species from the human histamine N-methyltransferase gene. Genomics. 83(1). 168–171. 3 indexed citations
12.
Herrick‐Davis, Katharine, Ellinor Grinde, & Milt Teitler. (2000). Inverse Agonist Activity of Atypical Antipsychotic Drugs at Human 5-Hydroxytryptamine2C Receptors. Journal of Pharmacology and Experimental Therapeutics. 295(1). 226–232. 136 indexed citations
13.
Egan, Christina, Ellinor Grinde, Ann DuPre, et al.. (2000). Agonist high and low affinity state ratios predict drug intrinsic activity and a revised Ternary complex mechanism at serotonin 5‐HT2A and 5‐HT2C receptors. Synapse. 35(2). 144–150. 1 indexed citations
14.
Herrick‐Davis, Katharine, Ellinor Grinde, & Colleen M. Niswender. (1999). Serotonin 5‐HT2C Receptor RNA Editing Alters Receptor Basal Activity. Journal of Neurochemistry. 73(4). 1711–1717. 147 indexed citations
15.
Grinde, Ellinor, et al.. (1998). Pharmacological Characterization of the Constitutively Activated State of the Serotonin 5‐HT2C Receptor. Annals of the New York Academy of Sciences. 861(1). 140–145. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026